Advertisement

ApoE Receptors in the Brain: Novel Signaling Pathways with Potential Relevance for Alzheimer’s Disease

  • J. Herz
  • U. Beffert
  • T. Hiesberger
  • M. Gotthardt
Conference paper
Part of the Research and Perspectives in Alzheimer’s Disease book series (ALZHEIMER)

Summary

Apolipoprotein E (ApoE) is an intrinsic component of lipoproteins and is known to transport cholesterol and other lipids through the circulation and between cells. ApoE binds to a family of cell surface receptors, the LDL receptor gene family. This class of endocytic receptors mediates the internalization of the lipoprotein particle, followed by transport of the lipids to the lysosomes. Several years ago, one isoform of ApoE, ApoE4, was reported to be genetically associated with late-onset Alzheimer’s disease. The biochemical mechanism by which ApoE4 predisposes its carriers to this debilitating neurodegenerative condition remains largely an enigma. We have investigated whether ApoE receptors on neurons are involved in the molecular pathogenic process. LRP, a member of the LDL receptor gene family, binds the amyloid precursor protein (APP) on its extracellular domain and is also connected to the cytoplasmic tail of APP by the adaptor protein FE65. This two-point interaction suggests that LRP may affect the subcellular localization, routing, and possibly processing of APP. Recently, we also described a novel signaling pathway by which two other members of the family, the VLDL receptor and the ApoE receptor 2, serve to transmit a positional cue across the membrane to migrating neurons. The signaling molecule, Reelin, binds to the receptor ectodomains and induces tyrosine phosphorylation of the intracellular adaptor protein Disabled-1. Disruption of this ApoE receptor-mediated signal transduction pathway results in hyperphosphorylation of the microtubule stabilizing protein tau, a prerequisite for the formation of neurofibrillary tangles in humans afflicted with Alzheimer’s disease. These findings tie neuronal ApoE receptors directly to two of the prominent pathological changes that are diagnostic for the disease: amyloid plaques, caused by abnormal processing of APP, and neurofibrillary tangles, caused by hyperphosphorylation of tau. We conclude that ApoE receptors regulate essential cellular signaling pathways in neurons and that defects in these pathways may accelerate the onset of Alzheimer’s disease.

Keywords

Amyloid Precursor Protein Familial Hypercholesterolemia Induce Tyrosine Phosphorylation ApoE Receptor Density Lipoprotein Receptor Gene Family 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34–47PubMedCrossRefGoogle Scholar
  2. Bu G, Williams S, Strickland DK, Schwartz AL (1992) Low density lipoprotein receptor-related protein/ a2-macroglobulin receptor is an hepatic receptor for tissue-type plasminogen activator. Proc Natl Acad Sci USA 89: 7427–7431PubMedCrossRefGoogle Scholar
  3. Chae T, Kwon YT, Bronson R, Dikkes P, Li E, Tsai LH (1997) Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality. Neuron 18: 29–42PubMedCrossRefGoogle Scholar
  4. D’Arcangelo G, Homayouni R, Keshvara L, Rice DS, Sheldon M, Curran T (1999) Reelin is a ligand for lipoprotein receptors. Neuron 24: 471–479PubMedCrossRefGoogle Scholar
  5. Herz J, Hamann U, Rogne S, Myklebost O, Gausepohl H, Stanley KK (1988) Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor. Embo J 7: 4119–4127PubMedGoogle Scholar
  6. Hiesberger T, Trommsdorff M, Howell BW, Goffinet A, Mumby MC, Cooper JA, Herz J (1999) Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24: 481–489PubMedCrossRefGoogle Scholar
  7. Howell BW, Hawkes R, Soriano P, Cooper JA (1997) Neuronal position in the developing brain is regulated by mouse disabled-1. Nature 389: 733–737PubMedCrossRefGoogle Scholar
  8. Howell BW, Herricks TM, Cooper JA (1999) Reelin-induced tyrosine phosphorylation of disabled-1 during neuronal positioning. Genes Dev 13: 643–648PubMedCrossRefGoogle Scholar
  9. Kim DH, Iijima H, Goto K, Sakai J, Ishii H, Kim HJ, Suzuki H, Kondo H, Saeki S, Yamamoto T (1996) Human apolipoprotein E receptor 2. A novel lipoprotein receptor of the low density lipoprotein receptor family predominantly expressed in the brain. J Biol Chem 271: 8373–8380Google Scholar
  10. Kounnas MZ, Moir RD, Rebeck GW, Bush AI, Argraves WS, Tanzi RE, Hyman BT, Strickland DK (1995) LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted 13-amyloid precursor protein and mediates its degradation. Cell 82: 331–340PubMedCrossRefGoogle Scholar
  11. Krieger M, Herz J (1994) Structures and functions of multiligand lipoprotein receptors: macrophage scavenger receptors and LDL receptor-related protein ( LRP ). Ann Rev Biochem 63: 601–637Google Scholar
  12. Kristensen T, Moestrup SK, Gliemann J, Bendtsen L, Sand O, Sottrup-Jensen L (1990) Evidence that the newly cloned low-density-lipoprotein receptor related protein (LRP) is the a2-macroglobulin receptor. FEBS Lett 276: 151–155PubMedCrossRefGoogle Scholar
  13. Mac Lachlan I, Nimpf J, Schneider WJ (1994) Avian riboflavin binding protein binds to lipoprotein receptors in association with vitellogenin. J Biol Chem 269: 24127–24132Google Scholar
  14. Novak S, Hiesberger T, Schneider WJ, Nimpf J (1996) A new low density lipoprotein receptor homologue with 8 ligand binding repeats in brain of chicken and mouse (published erratum appears in J Biol Chem 1996 Oct 25, 271(43): 27188). J Biol Chem 271: 11732–11736Google Scholar
  15. Nykjaer A, Petersen CM, Moller B, Jensen PA, Moestrup SK, Holtet TL, Etzerodt M, Thogersen HC, Munch M, Andreasen PA, Gliemann J (1992) Purified a2-macroglobulin receptor/LDL receptor-related protein binds urokinase:plasminogen activator inhibitor type-1 complex. J Biol Chem 267: 14543–14546PubMedGoogle Scholar
  16. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE (1999) An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3 (in process citation). Cell 96: 507–515PubMedCrossRefGoogle Scholar
  17. Ohshima T, Ward JM, Huh CG, Longenecker G, Veeranna Pant HC, Brady RO, Martin LJ, Kulkarni AB (1996) Targeted disruption of the cyclin-dependent kinase 5 gene results in abnormal corticogenesis, neuronal pathology and perinatal death. Proc Natl Acad Sci USA 93: 11173–11178PubMedCrossRefGoogle Scholar
  18. Orth K, Madison EL, Gething MJ, Sambrook JF, Herz J (1992) Complexes of tissue-type plasminogen activator and its serpin inhibitor plasminogen-activator inhibitor type 1 are internalized by means of the low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor. Proc Natl Acad Sci USA 89: 7422–7426PubMedCrossRefGoogle Scholar
  19. Patrick GN, Zukerberg L, Nikolic M, de la Monte S, Dikkes P, Tsai LH (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402: 615–622PubMedCrossRefGoogle Scholar
  20. Rice DS, Curran T (1999) Mutant mice with scrambled brains: understanding the signaling pathways that control cell positioning in the CNS. Genes Dev 13: 2758–2773PubMedCrossRefGoogle Scholar
  21. Rohlmann A, Gotthardt M, Hammer RE, Herz J (1998) Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J Clin Invest 101: 689–695PubMedCrossRefGoogle Scholar
  22. Saito A, Pietromonaco S, Loo AK, Farquhar MG (1994) Complete cloning and sequencing of rat gp330/“megalin,” a distinctive member of the low density lipoprotein receptor gene family. Proc Natl Acad Sci USA 91: 9725–9729PubMedCrossRefGoogle Scholar
  23. Schmechel DE, Saunders AM, Strittmatter WJ, Crain BJ, Hulette CM, Joo SH, Pericak-Vance MA, Goldgaber D, Roses AD (1993) Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer’s disease. Proc Natl Acad Sci USA 90: 9649–9653CrossRefGoogle Scholar
  24. Strickland DK, Ashcom JD, Williams S, Burgess WH, Migliorini M, Argraves WS (1990) Sequence identity between the a2-macroglobulin receptor and low density lipoprotein receptor-related protein suggests that this molecule is a multifunctional receptor. J Biol Chem 265: 17401–17404PubMedGoogle Scholar
  25. Takahashi S, Kawarabayasi Y, Nakai T, Sakai J, Yamamoto T (1992) Rabbit very low density lipoprotein receptor: a low density lipoprotein receptor-like protein with distinct ligand specificity. Proc Natl Acad Sci USA 89: 9252–9256PubMedCrossRefGoogle Scholar
  26. Trommsdorff M, Borg JP, Margolis B, Herz J (1998) Interaction of cytosolic adaptor proteins with neuronal apolipoprotein E receptors and the amyloid precursor protein. J Biol Chem 273: 33556–33560Google Scholar
  27. Trommsdorff M, Gotthardt M, Hiesberger T, Shelton J, Stockinger W, Nimpf J, Hammer RE, Richardson JA, Herz J (1999) Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97: 689–701PubMedCrossRefGoogle Scholar
  28. Webb DJ, Nguyen DH, Sankovic M, Gonias SL (1999) The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem 274: 7412–7420PubMedCrossRefGoogle Scholar
  29. Webb DJ, Nguyen DH, Gonias SL (2000) Extracellular signal-regulated kinase functions in the urokinase receptor-dependent pathway by which neutralization of low density lipoprotein receptor-related protein promotes fibrosarcoma cell migration and matrigel invasion (in process citation). J Cell Sci 113: 123–134PubMedGoogle Scholar
  30. Willnow TE, Hilpert J, Armstrong SA, Rohlmann A, Hammer RE, Burns DK, Herz J (1996) Defective forebrain development in mice lacking gp330/megalin. Proc Natl Acad Sci USA 93: 8460–8464PubMedCrossRefGoogle Scholar
  31. Willnow TE, Nykjaer A, Herz J (1999) Lipoprotein receptors: new roles for ancient proteins. Nature Cell Biol 1: E157 - E162PubMedCrossRefGoogle Scholar
  32. Yochem J, Greenwald I (1993) A gene for a low density lipoprotein receptor-related protein in the nematode Caenorhabditis elegans. J Biol Chem 268: 13002–13009Google Scholar
  33. Yochem J, Tuck S, Greenwald I, Han M (1999) A gp330/megalin-related protein is required in the major epidermis of Caenorhabditis elegans for completion of molting. Development 126: 597–606PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  • J. Herz
  • U. Beffert
  • T. Hiesberger
  • M. Gotthardt

There are no affiliations available

Personalised recommendations